What is the price-to-earnings ratio of Remedent?
The price-earnings ratio of Remedent is currently 0.
Remedent P/S 2024
Remedent P/S
0
Ticker
REMI
ISIN
US75954T1043
WKN
A0ERVL
As of Oct 3, 2024, Remedent's P/S ratio stood at 0, a 0% change from the 11.76 P/S ratio recorded in the previous year.
The Remedent P/S history
Remedent Aktienanalyse
What does Remedent do?
Remedent Inc is a company specialized in the development, manufacturing, and marketing of innovative dental products. It was founded in 1997 by Jürgen Steenwelle and Philippe de Bergeyck, with its headquarters in Mariakerke, Belgium. The company started with the creation of the GlamSmile veneer system, which revolutionized aesthetic dentistry. Remedent expanded its product portfolio to include teeth whitening systems, dental implants, dental instruments, and dental software solutions. The company aims to revolutionize the dental market with innovative technologies and materials. Remedent works closely with dental professionals worldwide to ensure the highest quality standards. It has locations in Europe, the USA, and Asia. Partnership with dentists and clinics is a key aspect of Remedent's business model, offering training and certifications to ensure proper and effective use of their products. The company is focused on global market expansion through strategic acquisitions and mergers to grow its customer base and promote technological advancements. Remedent has achieved impressive growth and success in a highly competitive market, remaining a significant provider of dental products and pursuing a strong growth strategy. Remedent ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Remedent's P/S Ratio
Remedent's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Remedent's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Remedent's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Remedent’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Remedent stock
How has the price-earnings ratio of Remedent changed compared to last year?
The price-to-earnings ratio of Remedent has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Remedent high compared to other companies?
Yes, the price-to-earnings ratio of Remedent is high compared to other companies.
How does an increase in the price-earnings ratio of Remedent affect the company?
An increase in the price-earnings ratio of Remedent would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Remedent affect the company?
A decrease in the price-earnings ratio of Remedent would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Remedent?
Some factors that influence the price-earnings ratio of Remedent are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Remedent pay?
Over the past 12 months, Remedent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Remedent is expected to pay a dividend of 0 USD.
What is the dividend yield of Remedent?
The current dividend yield of Remedent is .
When does Remedent pay dividends?
Remedent pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Remedent?
Remedent paid dividends every year for the past 0 years.
What is the dividend of Remedent?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Remedent located?
Remedent is assigned to the 'Health' sector.
Wann musste ich die Aktien von Remedent kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Remedent from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.
When did Remedent pay the last dividend?
The last dividend was paid out on 10/3/2024.
What was the dividend of Remedent in the year 2023?
In the year 2023, Remedent distributed 0 USD as dividends.
In which currency does Remedent pay out the dividend?
The dividends of Remedent are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Remedent
Our stock analysis for Remedent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Remedent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
